Tumer TB

References (3)

Title : Strigolactone Analogs: Two New Potential Bioactiphores for Glioblastoma - Antika_2022_ACS.Chem.Neurosci_13_572
Author(s) : Antika G , Cinar Z , Secen E , Ozbil M , Tokay E , Kockar F , Prandi C , Tumer TB
Ref : ACS Chem Neurosci , 13 :572 , 2022
Abstract :
PubMedSearch : Antika_2022_ACS.Chem.Neurosci_13_572
PubMedID: 35138812

Title : Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics - Sharifi-Rad_2020_J.Clin.Med_9_
Author(s) : Sharifi-Rad M , Lankatillake C , Dias DA , Docea AO , Mahomoodally MF , Lobine D , Chazot PL , Kurt B , Tumer TB , Moreira AC , Sharopov F , Martorell M , Martins N , Cho WC , Calina D , Sharifi-Rad J
Ref : J Clin Med , 9 : , 2020
Abstract :
PubMedSearch : Sharifi-Rad_2020_J.Clin.Med_9_
PubMedID: 32276438

Title : Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia - Tumer_2012_Arch.Toxicol_86_431
Author(s) : Tumer TB , Sahin G , Arinc E
Ref : Archives of Toxicology , 86 :431 , 2012
Abstract :
PubMedSearch : Tumer_2012_Arch.Toxicol_86_431
PubMedID: 21983886